Weight gain and lipid metabolic abnormalities induced by olanzapine in first-episode, drug-naïve patients with psychotic disorders

Lower weight gain with the orally disint

Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients

✍ B. Arranz; L. San; R.M. Dueñas; M. Centeno; N. Ramirez; J. Salavert; E. del Mora 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract ## Objective A post‐hoc analysis of the data from a randomised clinical trial involving prescription of antipsychotic treatment to never treated first‐onset psychotic patients was used to compare the weight change after 6‐week olanzapine treatment (standard tablets vs. orally disintegr